Trade Bristol Myers ^BMY

Bristol Myers' Camzyos Update Boosts Prospects for Cytokinetics (CYTK) | BMY Stock News

Natixis Sells 108,957 Shares of Bristol-Myers Squibb (NYSE:BMY)

Capital International Inc. CA Buys 18,178 Shares of Bristol-Myers Squibb (NYSE:BMY)

Commerce Bank Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

Short Interest in Bristol-Myers Squibb (NYSE:BMY) Drops By 20.6%

Capital Group Private Client Services Inc. Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Capital International Sarl Acquires 37,067 Shares of Bristol-Myers Squibb (NYSE:BMY)

Regal Investment Advisors LLC Cuts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Freedom Investment Management Inc. Raises Position in Bristol-Myers Squibb (NYSE:BMY)

Forum Financial Management LP Has $955,000 Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Canada Pension Plan Investment Board

Demars Financial Group LLC Acquires New Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Gamco Investors INC. ET AL

Bristol-Myers Squibb (BMY) Shares Decline Amid FDA Updates and Mixed Trial Results

Bristol-Myers Squibb (NYSE:BMY) Position Boosted by NewEdge Advisors LLC

Cadence Bank Sells 2,241 Shares of Bristol-Myers Squibb (NYSE:BMY)

Capital International Investors Has $2.59 Billion Stake in Bristol-Myers Squibb (NYSE:BMY)

One Mind's Rising Star Awards Celebrates 20 Years of Funding Innovative Mental Health Research | Morningstar

First Commonwealth Financial Corp PA Makes New $227,000 Investment in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Cut by Insigneo Advisory Services LLC

Bristol Myers (BMY) Gains FDA Nod for Updated Camzyos Label to Simplify Treatment | BMY Stock News

Bristol Myers says FDA updates Camzyos label to simplify treatment | Markets Insider

Stenger Family Office LLC Acquires Shares of 42,995 Bristol-Myers Squibb (NYSE:BMY)

NFJ Investment Group LLC Invests $12.56 Million in Bristol-Myers Squibb (NYSE:BMY)

United Capital Financial Advisors LLC Has $10.19 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Evotec SE (EVO) (Q4 2024) Earnings Call Highlights: Strong Q4 Performance and Strategic ...

Bristol-Myers Squibb Co (BMY) Announces FDA Updates for CAMZYOS Prescribing Information | BMY ...

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten)

Demars Financial Group LLC Makes New $49.87 Million Investment in Bristol-Myers Squibb (NYSE:BMY)

MSH Capital Advisors LLC Invests $534,000 in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers (BMY) Target Price Trimmed as Revenue Projections Dip | BMY Stock News

Bridgewater Associates LP Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

M Holdings Securities Inc. Buys Shares of 12,202 Bristol-Myers Squibb (NYSE:BMY)

Mariner LLC Raises Holdings in Bristol-Myers Squibb (NYSE:BMY)

SageView Advisory Group LLC Buys 7,168 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers' heart disease drug fails to meet main goals in late-stage study

Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?

Chiron Investment Management LLC Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)

Canada Post Corp Registered Pension Plan Acquires New Stake in Bristol-Myers Squibb (NYSE:BMY)

Belpointe Asset Management LLC Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Trustmark National Bank Trust Department

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Summit Investment Advisors Inc.

Sagespring Wealth Partners LLC Acquires New Position in Bristol-Myers Squibb (NYSE:BMY)

Rockefeller Capital Management L.P. Decreases Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb (BMY) Partners with Optellum for AI Lung Cancer Diagnosis

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?

Cytokinetics (CYTK) Gains Favor as Key Trial by Bristol-Myers Falls Short | CYTK Stock News

BofA Adjusts Price Target for Cytokinetics (CYTK) Amid Competitive Developments | BMY Stock News

Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung ...

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Savvy Advisors Inc.

Bristol-Myers Squibb (NYSE:BMY) Position Trimmed by Synovus Financial Corp

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Independent Franchise Partners LLP

Blackhill Capital Inc. Buys 8,700 Shares of Bristol-Myers Squibb (NYSE:BMY)

Ontario Teachers Pension Plan Board Acquires 13,394 Shares of Bristol-Myers Squibb (NYSE:BMY)

Advisors Capital Management LLC Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Townsquare Capital LLC Has $12.86 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Failure to make findings of fact adds twist to battle over Eliquis in Ireland

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation

PD-1 Non-Small Cell Lung Cancer Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | ABNewswire

Hearing Loss & Heart Failure; BP Drug Released From REMS; Fecal Transplants for PAH? | MedPage Today

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis

Bristol Myers Squibb (BMY) Sees Stock Dip as Camzyos Trial Falls Short

Bristol Myers' Heart Disease Drug Fails To Meet Primary Endpoints In Phase 3 Trial

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial | BMY Stock News

Bristol Myers (BMY) Reports Unmet Goals in Key Trial for Camzyos | BMY Stock News

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints | Markets Insider

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Petros Family Wealth LLC Acquires Shares of 9,555 Bristol-Myers Squibb (NYSE:BMY)

HDAC Inhibitors Market Projected to Grow Significantly Through 2034 | DelveInsight | ABNewswire

Bristol-Myers Squibb (NYSE:BMY) Price Target Cut to $54.00 by Analysts at UBS Group

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by WealthTrust Axiom LLC

Scotia Capital Inc. Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by DRW Securities LLC

Zuckerman Investment Group LLC Lowers Stake in Bristol-Myers Squibb (NYSE:BMY)

Treasurer of the State of North Carolina Has $59.41 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)

LSV Asset Management Trims Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Renaissance Technologies LLC

Bank of Nova Scotia Purchases 116,513 Shares of Bristol-Myers Squibb (NYSE:BMY)

Rep. Greg Landsman Sells Bristol-Myers Squibb (NYSE:BMY) Shares

Bristol-Myers Squibb Co (BMY) Gains FDA Approval for Opdivo and Yervoy in Liver Cancer ...

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Bristol Myers Squibb (BMY) Secures FDA Approval for Liver Cancer Treatment

FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas | Morningstar

Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?

Bristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatment | Markets Insider

Cipla's generic drug for cancer gets U.S. FDA nod - The Hindu

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by APG Asset Management US Inc.

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Martingale Asset Management L P

Cipla cancer generic receives FDA final nod

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Advisory Services Network LLC

Rathbones Group PLC Sells 5,603 Shares of Bristol-Myers Squibb (NYSE:BMY)

Cipla jumps on receiving approval from USFDA for protein-bound Paclitaxel | Capital Market News - Business Standard

Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling

Summit Financial Wealth Advisors LLC Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers (BMY) Experiences Increased Bearish Options Activity Ahead of Earnings | BMY ...

Bristol-Myers Squibb on Pace for Largest Percent Decrease in Nearly a Year - Data Talk | Morningstar

APG Asset Management N.V. Has $87.85 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty

Morning Note: Dollar Falls on Trump-Fed Fears; Japan in US Trade Talks; China holds rates

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Stock market today: Nifty above 24,400, Sensex up 309 points

Morning Note: Fed Cautious on Tariffs; US-Japan Currency Tensions; Oil Up

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold